The clinical introduction of a radioactive and fluorescent hybrid tracer allowed for preoperative lymphatic mapping and intraoperative real-time fluorescence tracing of the sentinel lymph node (SLN) by a single injection. The aim of this feasibility study is to evaluate the first-in-human use of the hybrid tracer by combining indocyanine green (ICG) and radiocolloid based on Nanotop compound (Tc Nanotop) for SLN biopsy (SLNB) in breast cancer patients.
Novel Experience in Hybrid Tracers: Clinical Evaluation of Feasibility and Efficacy in Using ICG-99mTC Nanotop for Sentinel Node Procedure in Breast Cancer Patients
Manca, Gianpiero;Garau, Ludovico Maria;Mazzarri, Sara;Muccioli, Simona;Naccarato, Giuseppe;Roncella, Manuela;Volterrani, Duccio;
2021-01-01
Abstract
The clinical introduction of a radioactive and fluorescent hybrid tracer allowed for preoperative lymphatic mapping and intraoperative real-time fluorescence tracing of the sentinel lymph node (SLN) by a single injection. The aim of this feasibility study is to evaluate the first-in-human use of the hybrid tracer by combining indocyanine green (ICG) and radiocolloid based on Nanotop compound (Tc Nanotop) for SLN biopsy (SLNB) in breast cancer patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
58-CNM-2021.pdf
non disponibili
Tipologia:
Versione finale editoriale
Licenza:
NON PUBBLICO - accesso privato/ristretto
Dimensione
444.76 kB
Formato
Adobe PDF
|
444.76 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
Ultimo VerdeNano_29 september_MG_2020 (1).docx
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
594.19 kB
Formato
Microsoft Word XML
|
594.19 kB | Microsoft Word XML | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
